Inpo leuwih ― Urang sundan

Urticaria ilaharna hadir kalawan welts diangkat intensely itchy. Kadang-kadang dibarengan ku bareuh tina jaringan dasar. Pangobatan utamina ngalibatkeun ngahindarkeun pemicu, upami dipikanyaho. Pangobatan lini kahiji kalebet antihistamin énggal, anu tiasa disaluyukeun kana dosis anu langkung luhur upami diperyogikeun. Pangobatan sanés sapertos antihistamin anu langkung lami, pameungpeuk H2, antagonis reséptor leukotrien, antihistamin anu langkung kuat, sareng kursus pondok kortikosteroid tiasa ditambihan salaku dukungan tambahan. Dina kasus urticaria persists sanajan ukuran ieu, penderita bisa dirujuk ka spesialis pikeun terapi tambahan kayaning omalizumab atawa cyclosporine.
Urticaria commonly presents with intensely itchy raised welts. It is sometimes accompanied by swelling of the underlying tissues. Treatment primarily involves avoiding triggers, if known. First-line medication includes newer antihistamines, which can be adjusted to higher doses if needed. Other medications like older antihistamines, H2 blockers, leukotriene receptor antagonists, stronger antihistamines, and short courses of corticosteroids can be added as extra support. In cases where urticaria persists despite these measures, patients might be referred to specialists for additional therapies such as omalizumab or cyclosporine.

Tinjauan ieu ngagariskeun tungtunan pangénggalna pikeun ngubaran urtikaria sareng nawiskeun pamahaman énggal ngeunaan panyababna.
This review outlines the latest guidelines for treating urticaria and offers new understandings of its causes.

Second-generation H1-antihistamines (e.g., cetirizine, loratadine, fexofenadine), Omalizumab, Ciclosporin, and short courses only of systemic corticosteroids